EP0726913A4 - Citokine aus natuerlichen killer oder - t - zellen - Google Patents
Citokine aus natuerlichen killer oder - t - zellenInfo
- Publication number
- EP0726913A4 EP0726913A4 EP95901809A EP95901809A EP0726913A4 EP 0726913 A4 EP0726913 A4 EP 0726913A4 EP 95901809 A EP95901809 A EP 95901809A EP 95901809 A EP95901809 A EP 95901809A EP 0726913 A4 EP0726913 A4 EP 0726913A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cytokines
- cells
- natural killer
- killer
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5403—IL-3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15051093A | 1993-11-10 | 1993-11-10 | |
US150510 | 1993-11-10 | ||
PCT/US1994/012835 WO1995013294A1 (en) | 1993-11-10 | 1994-11-08 | Cytokines from natural killer or t cells |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0726913A1 EP0726913A1 (de) | 1996-08-21 |
EP0726913A4 true EP0726913A4 (de) | 2000-01-26 |
Family
ID=22534880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95901809A Withdrawn EP0726913A4 (de) | 1993-11-10 | 1994-11-08 | Citokine aus natuerlichen killer oder - t - zellen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0726913A4 (de) |
JP (1) | JPH09505285A (de) |
AU (1) | AU1090895A (de) |
CA (1) | CA2176114A1 (de) |
WO (1) | WO1995013294A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
-
1994
- 1994-11-08 JP JP7513935A patent/JPH09505285A/ja active Pending
- 1994-11-08 EP EP95901809A patent/EP0726913A4/de not_active Withdrawn
- 1994-11-08 CA CA002176114A patent/CA2176114A1/en not_active Abandoned
- 1994-11-08 WO PCT/US1994/012835 patent/WO1995013294A1/en not_active Application Discontinuation
- 1994-11-08 AU AU10908/95A patent/AU1090895A/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
No further relevant documents disclosed * |
See also references of WO9513294A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU1090895A (en) | 1995-05-29 |
WO1995013294A1 (en) | 1995-05-18 |
JPH09505285A (ja) | 1997-05-27 |
CA2176114A1 (en) | 1995-05-18 |
EP0726913A1 (de) | 1996-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9300281D0 (en) | Antimicrobial-protein-producing endosymbiotic micro-organisms | |
GB9125623D0 (en) | Cell modification | |
EP0582389A3 (en) | Easel | |
EP0516958A3 (en) | Caffeoyl-coa-3-o-methyltransferase gene | |
DE69326254D1 (en) | Membrane | |
GB9311252D0 (en) | Cell growth regualtors | |
ZA934807B (en) | Growth medium | |
IL109333A0 (en) | Genetic stabilizing elements | |
GB2280830B (en) | Fishing floats | |
GB9313598D0 (en) | Aquarium improvements | |
EP0726913A4 (de) | Citokine aus natuerlichen killer oder - t - zellen | |
GB9202797D0 (en) | Glazed units | |
GB2272370B (en) | An easel | |
GB2296365B (en) | Sounder | |
GB9200349D0 (en) | The inverted aquarium | |
GB9312488D0 (en) | Slingshot | |
KR940020812U (ko) | 건축물 바닥골조용 데크(deck) | |
GB9313011D0 (en) | Deck structure | |
GB9412952D0 (en) | Killer cells | |
ZA94834B (en) | Membrane arrangements | |
PHUM7845Z (en) | Mosquito killer | |
KR950000730Y1 (en) | Aquarium | |
KR940001345Y1 (en) | Aquarium | |
GB9216603D0 (en) | Float case | |
GB9203400D0 (en) | Fast free fall lifeboat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960528 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19991210 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19960611 |